Cargando…
SARS-CoV-2 vaccination in the immunocompromised host
Autores principales: | Connolly, Caoilfhionn M., Paik, Julie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095497/ https://www.ncbi.nlm.nih.gov/pubmed/35568078 http://dx.doi.org/10.1016/j.jaci.2022.05.001 |
Ejemplares similares
-
Does pollen exposure influence innate immunity to SARS-CoV-2 in allergy or asthma?
por: Hajighasemi, Saeideh, et al.
Publicado: (2023) -
Perforin and resistance to SARS coronavirus 2
por: Cunningham, Louise, et al.
Publicado: (2020) -
The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin: SARS‐COV‐2 chimeric structure and furin cleavage site might be the result of genetic manipulation
por: Segreto, Rossana, et al.
Publicado: (2020) -
Management of patients with immediate reactions to COVID-19 vaccines
por: Picard, Matthieu, et al.
Publicado: (2023) -
Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)